medigraphic.com
ISSN 0185-3325 (Print)
Órgano Oficial del Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz

2001, Number 2

<< Back Next >>

Salud Mental 2001; 24 (2)

Teorema del trastorno obsesivo-compulsivo

Yaryura-Tobías JA, Neziroglu F

Language: Spanish
References: 43
Page: 11-15
PDF size: 135.88 Kb.


ABSTRACT

The obsessive-compulsive disorder (OCD) presents a symptomatic diversity that seems to reflect several cerebral regions. The hypothesis of work indicates that to a larger number of symptoms less cerebral localization is found . That is to say, the symptomatic heterogenicity cannot be reduced to one single cerebral area. Therefore, it is required to corroborate the anatomical-histochemical findings, the current semiology, and the presence or not of OCD spectrum disorder. It is assumed that the theorem confirms the presence of cerebral lesions in different areas of the brain in patients with OCD. Besides, the histochemical progression of the neurotransmitters from the posterior part of the brain (locus coeruleus and raphe) forward, and the putative cerebral loops of the OCD, constitute a corroborative factor to the theorem hypothesis.


REFERENCES

  1. AAKERLUND L, HEMMINGSEN R: Neural networks as models of psychopathology. Biol Psychiatry, 43:471-482, 1998.

  2. ALEXANDER CE, CRUTCHER MD, DELONG MR: Basal ganglia-thalamocortical circuits: Parallel substrates for motor, oculomotor, “prefrontal” and “limbic” functions. Prog Brain Res, 85:119-146, 1990.

  3. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders (4a ed., DSM-IV). Washington, 1994.

  4. AYLWARD EH, SCHWARTZ J, MACHLIN S, PEARLSON G: Bicaudate ratio as a measure of caudate volume on MR images. Am J Neuroradiol, 12:1217-1222, 1991.

  5. BAXTER LR, SAXENA S, BRODY AL y cols: Brain mediation of obsessive-compulsive disorder symptoms: evidence from functional brain imaging studies in the human and nonhuman primate. Semin Clin Neuropsychiatry, 1:32-47, 1996.

  6. BAXTER LR, PHELPS ME, MAZZIOTTA JC y cols: Local cerebral glucose metabolic rates in obsessive compulsive disorder: a comparison with rates in unipolar depression and in normal controls. Arch Gen Psychiatry, 44:211-218, 1987.

  7. BROCHER T, HANTOUCHE E: Analyse critique des études pharmacologiques contrôlées dans le trouble obsessionnelcompulsif. L’Encéphale, 15(3):325-333, 1989.

  8. BRODY AL, SAXENA S: Brain imaging in obsessive compulsive disorder: evidence for the involvement of frontalsubcortical circuitry in mediation of symptomatology. CNS Spectrums, 1:27-42, 1996.

  9. BUNGE M: Emergence and the mind. Neuroscience, 2(4):501-509, 1977.

  10. CABALEIRO-GOAS M: Las obsesiones y las fobias. En: Temas Psiquiátricos. Paz Montalvo (ed.), VIII, Madrid, 1966.

  11. COSTA-MOLINARI JM, EGUILLOR M, ROMEU J, TIZON J: Patolgía Obsesiva. En: Esteve SM, Costa-Molinari JM, Ballus C (eds.), Graficasa, XI: 253, Málaga, 1971.

  12. CREASEY H, RAPOPORT SL: The aging human brain. Ann Neurol, 17:2-10, 1985.

  13. ENGEL GL: The clinical application of the biopsychosocial model. Am J Psychiatry, 137(5):535-544, 1980.

  14. GARBER JH, ANANTH JV, CHIU IC, GRISWOLD VJ,OLDENDORF WH: Nuclear magnetic resonance study of obsessive compulsive disorder. Am J Psychiatry, 146:1001- 1005, 1989.

  15. GOLDAR JC, ROJAS D, OUTES M: Cerebral mechanisms in obsessive-compulsive disorder. CNS Spectrums, 3(7):44- 46, 1998.

  16. HOCHE AE: Die bedeutung der symptomkomplese in der psychiatric. Z Ges Neurol Psychiat, 12:540-541, 1912.

  17. INGRAM IM: Obsessional illness in mental hospital patients.J Ment Sci, 107:382-396, 1961.

  18. INSEL TR: Obsessive-compulsive disorder: New models.Pharmacol Bull, 24(3):365-369, 1988.

  19. IRLE E, EXNER C, THIELEN K y cols: Obsessivecompulsive disorders and ventromedial frontal lesions: clinical and neuropsychological findings. Am J Psychiatry, 155: 255-263, 1998.

  20. KNOLKER U: EEG frequency analyses in children and adolescents with obsessive-compulsive neuroses. Z Kinder Jugenpsychiatr, 16:180-185, 1988.

  21. LAFER B, RENSHAW PF, SACHS GS: Major depression and the basal ganglia. Psychiatr Clin North Am, 20(4):885-896, 1997.

  22. LEONARD HL, SWEDO SE, RAPOPORT JL, KOBY EV,LENANE MC, CHESLOW DL, HAMBURGER SD: Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents. A double-blind crossover comparison. Arch Gen Psychiatry,46(12):1088-1092, 1989.

  23. LUYS M: Des obsessions pathologiques dans leurs rapports avec l’activité automatique des éléments nerveux. L’Encéphale, 3:20-61, 1983.

  24. MACKAY DM: Selves and brains. Neuroscience, 3:599-606, 1978.

  25. OKASHA A, RASFAT M: Neurophysiological substrate of obsessive compulsive disorder: an evidence from topographic EEG. Egypt J Psychiatry, 13:97-106, 1990.

  26. OROZCO B, DE LA RUENTE JR, NICOLINI H: Bases bioquímicas y tratamiento farmacológico del trastorno obsesivo compulsivo: experiencia del IMP en 70 pacientes. Salud Mental, 18(1):1-13, 1995.

  27. PERROS P, YOUNG ES, RITSON JJ, PRICE GW: Power spectral EEG analysis and EEG variability in obsessive compulsive disorder. Brain Topogr, 4:187-192, 1992.

  28. RAPOPORT JL, WISE SP: Obsessive-compulsive disorder: Evidence for basal ganglia dysfunction. Psychopharmacol Bull, 24:380-384, 1998.

  29. RAUCH SL, DOUGHERTY DD, SHIN LM, ALPERT NM, MANZO P, LEAHY L, FISCHMAN AJ, JENIKE MA, BAER L: Neural correlates of factor-analyzed OCD symptom dimensions: A PET Study. CNS Spectrums, 3(7):37-43, 1998.

  30. RUBIN RT, VILLANUEVA-MEYER J, ANATH J,TRAJMAR PG, MENA I: Regional Xenon 133 cerebral blook flow and cerebral technetium 99m HM-PAO uptake in unmedicated patients with obsessive-compulsive disorder and matched normal control subjects. Determination by highresolution single-photon emission computed tomography. Arch Gen Psychiatry, 49:695-702, 1992.

  31. RÜDIN E: Ein Beitrag zur frage der zwang krankheit,insbesondere ihrer hereditaren beziehungen. Arch Psychiat Nervenkr, 191:14-54, 1953.

  32. SWEDO SE, LEONARD HL, GARVEY M, MITTLEMAN B, ALLEN AJ, PERLMUTTER SD y cols: Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: Clinical description of the first 50 cases. Am J Psychiatry, 155(2):264-271, 1998.

  33. TRIVEDI MH: Functional neuroanatomy of obsessivecompulsive disorder. J Clin Psychiatry, 57(Supl. 8):26-35, 1996.

  34. VON BERTALANFFY L: Chance of law. En: Koestler A,Synthies Jr. (eds.). Beyond Reductionism. Macmillan Publishing Co, Nueva York, 1969.

  35. YARYURA-TOBIAS JA, GRUNES MS, TODARO J, McKAY D, NEZIROGLU FA, STOCKMAN R: Nosological insertion of axis I disorders in the etiology of obsessivecompulsive disorder. J Anxiety Disord, 14(1):19-30, 2000.

  36. YARYURA- TOBIAS JA, NEZIROGLU F, PEREZRIVERA RL: Teoría unificada del trastorno obsesivocompulsivo. Acta Psiquiátrica Psicológica América Latina, 45(4):339-347, 1999.

  37. YARYURA-TOBIAS JA, STEVENS KP, NEZIROGLU FA: Motor disturbances in the obsessive-compulsive disorder and its spectrum. Neurol Psychiatry Brain Res, 5:79-84, 1997a.

  38. YARYURA-TOBIAS JA, STEVENS K, NEZIROGLU FA,ANDERSON M: Aspectos catatónicos del trastorno obsesocompulsivo. Asociación Argentina de Psiquiatras (Comunicaciones), 6:10-15, 1997b.

  39. YARYURA-TOBIAS JA: The unified theory of obsessive compulsive disorder. CNS Spectrums. International J Neuropsychiatric Medicine, 3(7):54-60, 1998.

  40. YARYURA-TOBIAS JA, CAMPISI TA, McKAY D,NEZIROGLU FA: Schizophrenia and obsessive-compulsive disorder: Shared aspects of pathology. Neurol Psychiatry Brain Res, 3:143-148, 1995.

  41. YARYURA-TOBIAS JA, NEZIROGLU FA: Organicity in obsessive compulsive disorder. Biol Psychiatry, 29:337-340, 1991.

  42. YARYURA-TOBIAS JA: Symptoms and classification of obsessive compulsive disorders. Biol Psychiatry, 521-523, 1986.

  43. YARYURA-TOBIAS JA, BEBIRIAN R, NEZIROGLU F,BHAGAVAN HN: Obsessive-compulsive disorders as a serotonergic defect. Research Communications Psychology, Psychiatry, Behavior, 2:279-286, 1977.




2020     |     www.medigraphic.com